CTX611
LIVE

Serial Number

99583006

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

Filing Date

Jan 7, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CTX611 Trademark

Serial Number: 99583006

CTX611 is a trademark filed by CRISPR Therapeutics AG on January 7, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

January 7, 2026

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of gene therapy

Cells for medical or clinical use in the field of gene therapy for the treatment of cardiovascular diseases and thromboembolic diseases and disorders; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular diseases and thromboembolic diseases and disorders in the field of gene therapy

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2026 CNSA
ASSIGNED TO EXAMINER
May 6, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 7, 2026 MAFR
NEW APPLICATION ENTERED
Jan 7, 2026 NWAP